Creative Medical Technology Holdings Inc

NASDAQ:CELZ   1:41:52 PM EDT
0.41
0.00 (+0.49%)
Earnings Announcements

Creative Medical Technology Announces Peer Reviewed Publication Of Positive Results For Stemspine Study

Published: 09/26/2022 12:31 GMT
Creative Medical Technology Holdings Inc (CELZ) - Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for Stemspine Study.
Creative Medical Technology - 2 Year Follow-up Results Confirm Efficacy & Noserious Adverse Effects in Patients Who Used Stemspine Procedure.
Creative Medical Technology - Stemspine Procedure Resulted in Efficacy Rate of 87% in Treated Patients in Terms of Decreased Pain and Increased Mobility.
Revenue is expected to be $0.11 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $0.31 Million
Next Quarter EPS Guidance is expected to be -$0.13

More details on our Analysts Page.